CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
51 hedge funds and large institutions have $19.3M invested in Carisma Therapeutics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $26.6M → $19.3M (-$7.3M)
42% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 19
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$88.5K | |
| 2 | +$62.8K | |
| 3 | +$56.3K | |
| 4 |
Two Sigma Investments
New York
|
+$34.5K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$29.6K |
Top Sellers
| 1 | -$527K | |
| 2 | -$298K | |
| 3 | -$281K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$218K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$81.6K |